Targeting aspirin in acute disabling ischemic stroke: An individual patient data meta-analysis of three large randomized trials

International Journal of Stroke

Volumn 10, Issue 7, 2015, Pages 1024-1030

  Thompson, Douglas D ^a   Murray, Gordon D ^a   Candelise, Livia ^b   Chen, Zhengming ^c   Sandercock, Peter A G ^a   Whiteley, William N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Individual patient data meta analysis; Prediction; Randomized clinical trials; Stratified treatment; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; FIBRINOLYTIC AGENT;

ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DEEP VEIN THROMBOSIS; FOLLOW UP; FUNCTIONAL ASSESSMENT; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; META ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; COMPLICATION; FEMALE; INTRACRANIAL HEMORRHAGES; MALE; MOLECULAR GENETICS; MULTICENTER STUDY (TOPIC); RISK FACTOR; STROKE; THROMBOSIS;

ASPIRIN; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MOLECULAR SEQUENCE DATA; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STROKE; THROMBOSIS;

EID: 84942297307     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12487     Document Type: Article

References (18)

1. Sandercock PAG, Counsell C, Gubitz GJ, Tseng M-C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2008; (3):CD000029.
2. Wang Y, Wang Y, Zhao X etal. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. NEJM 2013; 369:11-19.
3. Rödén-Jüllig Å, Britton M, Malmkvist K, Leijd B. Aspirin in the prevention of progressing stroke: a randomized controlled study. J Intern Med 2003; 254:584-590.
4. Pince J. Thromboses veineuses des membres inferieures et embolies pulmonaires au cours des accidents vasculaires cerebraux. A propos d'un essai comparatif de traitment preventif. MD thesis. Toulouse: Université Paul Sabatier. 1981.
5. IST Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349:1569-1581.
6. Multicentre Acute Stroke Trial - Italy Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 1995; 346:1509-1514.
7. Zheng-Ming C. CAST: randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke. Lancet 1997; 349:1641-1649.
8. Altman DG, Vergouwe Y, Royston P, Moons KGM. Prognosis and prognostic research: validating a prognostic model. BMJ 2009; 338:b605.
9. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-387.
10. Steyerberg EW. Clinical Prediction Models: a Practical Approach to Development, Validation, and Updating. New York, Springer, 2009.
11. Vergouwe Y, Royston P, Moons KGM, Altman DG. Development and validation of a prediction model with missing predictor data: a practical approach. J Clin Epidemiol 2010; 63:205-214.
12. Janssen K, Vergouwe Y, Kalkman C, Grobbee D, Moons K. A simple method to adjust clinical prediction models to local circumstances. Can J Anaesth 2009; 56:194-201.
13. Glasziou P, Mant D. Applying results to treatment decisions in primary care; in Rothwell PM, (ed.): The Lancet: Treating Individuals From Randomized Trials to Personalized Medicine Barcelona. Barcelona, Spain, Elsevier, 2007:83-95.
14. Bouwmeester W, Zuithoff NPA, Mallett S etal. Reporting and methods in clinical prediction research: a systematic review. PLoS Med 2012; 9:e1001221.
15. Chen Z, Sandercock P, Pan H etal. Indications for early aspirin use in acute ischemic stroke : a combined analysis of 40000 randomized patients from the chinese acute stroke trial and the international stroke trial. Stroke 2000; 31:1240-1249.
16. Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol 2010; 9:105-118.
17. Ndrepepa G, Berger PB, Mehilli J etal. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 2008; 51:690-697.
18. Pocock SJ, Mehran R, Clayton TC etal. Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the acute catheterization and urgent intervention triage strategy trial. Circulation 2010; 121:43-51.